- |||||||||| Enrollment closed, Phase classification, Enrollment change, Trial primary completion date: Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=26, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Phase classification: P2 --> PN/A | N=35 --> 26 | Trial primary completion date: Dec 2016 --> May 2017
- |||||||||| Tysabri (natalizumab) / Biogen, Royalty
Enrollment closed, Enrollment change, HEOR: PROTYS: Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab (clinicaltrials.gov) - Feb 8, 2017 P=N/A, N=47, Active, not recruiting, Recruiting --> Active, not recruiting | Phase classification: P2 --> PN/A | N=35 --> 26 | Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Active, not recruiting | N=88 --> 47
- |||||||||| Enbrel (etanercept) / Pfizer, Amgen
Trial termination: Etanercept in Rheumatoid Arthritis and Vascular Inflammation (clinicaltrials.gov) - Feb 7, 2017 P4, N=5, Terminated, N=24 --> 4 | Suspended --> Terminated | Trial primary completion date: Aug 2017 --> Dec 2015; Company decision Active, not recruiting --> Terminated; Recruitment difficulties
- |||||||||| Nucala (mepolizumab) / GSK
Enrollment closed: Anti-IL-5 Therapy in Bullous Pemphigoid (BP) (clinicaltrials.gov) - Feb 7, 2017 P2, N=32, Active, not recruiting, No longer recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Trial completion, Trial initiation date: SisSLE: Autoimmunity in Sisters of Lupus Patients (clinicaltrials.gov) - Feb 6, 2017
P=N/A, N=817, Completed, Recruiting --> Completed Active, not recruiting --> Completed | Initiation date: Dec 2009 --> Feb 2009
- |||||||||| Biomarker, Enrollment closed: Salivary Biomarkers for Sj (clinicaltrials.gov) - Feb 6, 2017
P=N/A, N=420, Active, not recruiting, Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- |||||||||| Enrollment open, Phase classification, Trial initiation date, Trial primary completion date: Task-oriented Circuit Training Combined With Cerebellar tDCS in Multiple Sclerosis Subjects (clinicaltrials.gov) - Feb 3, 2017
P=N/A, N=30, Recruiting, Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Phase classification: P2 --> PN/A | Initiation date: May 2016 --> Feb 2017 | Trial primary completion date: Dec 2016 --> Jul 2017
- |||||||||| Trial completion, Enrollment change: Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy (clinicaltrials.gov) - Feb 3, 2017
P=N/A, N=115, Completed, Not yet recruiting --> Recruiting | Phase classification: P2 --> PN/A | Initiation date: May 2016 --> Feb 2017 | Trial primary completion date: Dec 2016 --> Jul 2017 Recruiting --> Completed | N=145 --> 115
- |||||||||| Trial completion, Enrollment change: The Health Log: A Randomized Clinical Trial (clinicaltrials.gov) - Feb 1, 2017
P=N/A, N=67, Completed, Recruiting --> Active, not recruiting | N=86 --> 108 | Trial primary completion date: Aug 2014 --> Jun 2017 Active, not recruiting --> Completed | N=150 --> 67
|